Roberto Fiammengo-rekin lankidetzan egindako argitalpenak (8)

2024

  1. Detection of Tumor-Associated Autoantibodies in the Sera of Pancreatic Cancer Patients Using Engineered MUC1 Glycopeptide Nanoparticle Probes

    Angewandte Chemie - International Edition, Vol. 63, Núm. 37

  2. Structure-Guided Approach for the Development of MUC1-Glycopeptide-Based Cancer Vaccines with Predictable Responses

    JACS Au, Vol. 4, Núm. 1, pp. 150-163

2023

  1. Evaluation of the immunostimulant properties of carbon dot nanoparticles as carriers for cancer vaccines

    XXXIX Reunión Bienal de Química RSEQ

  2. Evaluation of the immunostimulant properties of carbon dot nanoparticles as self-adjuvating cancer vaccines

    Jornadas Posdoctorales Campus Iberus Postdoctoral Days

  3. Methyl-to-Ethyl Replacement Makes the Difference: Structure-Guided Design of a New Cancer Vaccine Based on a Tn An-gen Surrogate

    VI RSEQ Chemical Biology Group Meeting - ChemBio VI

2022

  1. Carbon Dot-MUC1 conjugates: synthesis and applications of novel self-adjuvating cancer vaccines

    5th Glycobasque Meeting

2019

  1. Design and implementation of gold-nanoparticle formulations as MUC1-directed cancer vaccines

    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY

  2. Structure-Based Design of Potent Tumor-Associated Antigens: Modulation of Peptide Presentation by Single-Atom O/S or O/Se Substitutions at the Glycosidic Linkage

    Journal of the American Chemical Society, Vol. 141, Núm. 9, pp. 4063-4072